Athens Medical Center (0ONM) Ratios
Athens Medical Center Ratios
GB:0ONM's free cash flow for Q2 2026 was $-15.87M. For the 2026 fiscal year, GB:0ONM's free cash flow was decreased by $-8.31M and operating cash flow was $-7.55M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.76 | 0.83 | 0.98 | 1.10 | 1.21 |
| Quick Ratio | 0.74 | 0.80 | 0.95 | 1.05 | 1.16 |
| Cash Ratio | 0.11 | 0.08 | 0.11 | 0.11 | 0.77 |
| Solvency Ratio | 0.03 | 0.05 | 0.06 | 0.07 | 0.02 |
| Operating Cash Flow Ratio | 0.02 | 0.20 | 0.13 | 0.00 | 0.12 |
| Short-Term Operating Cash Flow Coverage | 0.05 | 0.82 | 0.52 | 0.01 | 0.94 |
| Net Current Asset Value | $ -209.12M | $ -195.18M | $ -171.58M | $ -155.01M | $ -1.46B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.30 | 0.33 | 0.34 | 0.08 |
| Debt-to-Equity Ratio | 1.76 | 1.36 | 1.46 | 1.40 | 1.48 |
| Debt-to-Capital Ratio | 0.64 | 0.58 | 0.59 | 0.58 | 0.60 |
| Long-Term Debt-to-Capital Ratio | 0.37 | 0.39 | 0.45 | 0.52 | 0.53 |
| Financial Leverage Ratio | 5.13 | 4.57 | 4.39 | 4.05 | 17.87 |
| Debt Service Coverage Ratio | 0.24 | 0.44 | 0.54 | 1.11 | 1.38 |
| Interest Coverage Ratio | 0.34 | 1.43 | 2.44 | 2.37 | 3.20 |
| Debt to Market Cap | 0.93 | 0.97 | 0.87 | 1.04 | 0.91 |
| Interest Debt Per Share | 2.23 | 1.82 | 1.94 | 1.75 | 1.81 |
| Net Debt to EBITDA | 5.44 | 4.06 | 3.61 | 3.95 | 1.31 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.36% | 22.52% | 25.76% | 24.34% | 25.57% |
| EBIT Margin | 3.02% | 5.63% | 8.85% | 7.88% | 10.06% |
| EBITDA Margin | 10.08% | 11.86% | 14.63% | 13.82% | 15.76% |
| Operating Profit Margin | 1.41% | 5.65% | 8.94% | 7.89% | 9.46% |
| Pretax Profit Margin | -1.09% | 1.67% | 5.30% | 4.59% | 6.79% |
| Net Profit Margin | -1.69% | 0.66% | 3.13% | 2.93% | 6.66% |
| Continuous Operations Profit Margin | -1.67% | 0.70% | 3.16% | 2.96% | 5.33% |
| Net Income Per EBT | 155.25% | 39.59% | 58.99% | 63.90% | 98.12% |
| EBT Per EBIT | -77.27% | 29.46% | 59.31% | 58.21% | 71.77% |
| Return on Assets (ROA) | -0.88% | 0.36% | 1.69% | 1.64% | 0.83% |
| Return on Equity (ROE) | -4.49% | 1.64% | 7.44% | 6.63% | 14.75% |
| Return on Capital Employed (ROCE) | 1.59% | 5.75% | 8.34% | 6.75% | 1.27% |
| Return on Invested Capital (ROIC) | 1.11% | 1.95% | 4.12% | 4.02% | 1.55% |
| Return on Tangible Assets | -0.89% | 0.36% | 1.70% | 1.64% | 0.83% |
| Earnings Yield | -2.72% | 1.36% | 4.98% | 5.56% | 10.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.59 | 1.69 | 1.64 | 1.83 | 2.40 |
| Payables Turnover | 1.82 | 2.01 | 2.12 | 2.20 | 2.66 |
| Inventory Turnover | 28.04 | 29.01 | 27.63 | 25.22 | 24.03 |
| Fixed Asset Turnover | 0.92 | 0.92 | 0.95 | 0.92 | 0.30 |
| Asset Turnover | 0.52 | 0.54 | 0.54 | 0.56 | 0.12 |
| Working Capital Turnover Ratio | -5.16 | -12.79 | 46.92 | 11.00 | -10.83 |
| Cash Conversion Cycle | 42.10 | 46.16 | 63.80 | 48.62 | 29.81 |
| Days of Sales Outstanding | 229.41 | 215.43 | 223.09 | 199.77 | 151.92 |
| Days of Inventory Outstanding | 13.02 | 12.58 | 13.21 | 14.48 | 15.19 |
| Days of Payables Outstanding | 200.33 | 181.85 | 172.50 | 165.63 | 137.30 |
| Operating Cycle | 242.43 | 228.01 | 236.30 | 214.25 | 167.11 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.06 | 0.54 | 0.30 | 0.00 | 0.18 |
| Free Cash Flow Per Share | -0.14 | 0.23 | 0.04 | -0.18 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | 0.30 | 1.64 | 1.17 | 0.01 | 1.39 |
| Capital Expenditure Coverage Ratio | 0.30 | 1.74 | 1.17 | 0.01 | 1.40 |
| Operating Cash Flow Coverage Ratio | 0.03 | 0.32 | 0.17 | 0.00 | 0.10 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.17 | 0.10 | 0.00 | 0.07 |
| Free Cash Flow Yield | -6.89% | 15.13% | 2.35% | -12.79% | 3.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -36.80 | 73.66 | 20.07 | 17.99 | 9.74 |
| Price-to-Sales (P/S) Ratio | 0.62 | 0.49 | 0.63 | 0.53 | 0.65 |
| Price-to-Book (P/B) Ratio | 1.65 | 1.21 | 1.49 | 1.19 | 1.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.52 | 6.61 | 42.57 | -7.82 | 32.83 |
| Price-to-Operating Cash Flow Ratio | 33.75 | 2.82 | 6.20 | 993.27 | 9.31 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | -0.94 | 1.11 | -0.38 | 0.04 |
| Enterprise Value Multiple | 11.62 | 8.15 | 7.90 | 7.77 | 5.42 |
| Enterprise Value | 322.85M | 260.77M | 298.74M | 250.54M | 193.25M |
| EV to EBITDA | 11.62 | 8.15 | 7.90 | 7.77 | 5.42 |
| EV to Sales | 1.17 | 0.97 | 1.16 | 1.07 | 0.86 |
| EV to Free Cash Flow | -27.29 | 13.16 | 78.41 | -15.91 | 43.28 |
| EV to Operating Cash Flow | 63.45 | 5.61 | 11.42 | 2020.48 | 12.27 |
| Tangible Book Value Per Share | 1.11 | 1.18 | 1.22 | 1.18 | 2.17 |
| Shareholders’ Equity Per Share | 1.20 | 1.25 | 1.25 | 1.19 | 1.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.54 | 0.58 | 0.40 | 0.35 | 0.22 |
| Revenue Per Share | 3.18 | 3.11 | 2.98 | 2.69 | 2.61 |
| Net Income Per Share | -0.05 | 0.02 | 0.09 | 0.08 | 0.17 |
| Tax Burden | 1.55 | 0.40 | 0.59 | 0.64 | 0.98 |
| Interest Burden | -0.36 | 0.30 | 0.60 | 0.58 | 0.67 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.69 | 10.33 | 3.24 | 0.01 | 1.03 |
Currency in EUR
